Titre : Anti-infectieux

Anti-infectieux : Questions médicales fréquentes

Termes MeSH sélectionnés :

Surveys and Questionnaires

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment diagnostiquer une infection bactérienne ?

Un diagnostic se fait par des tests de culture et des analyses sanguines.
Infections bactériennes Diagnostic médical
#2

Quels tests pour une infection virale ?

Les tests PCR et les sérologies sont utilisés pour détecter les infections virales.
Infections virales Tests diagnostiques
#3

Comment identifier une mycose ?

Un examen microscopique et des cultures fongiques permettent d'identifier les mycoses.
Mycoses Diagnostic médical
#4

Quels signes indiquent une infection parasitaire ?

Des symptômes comme la fièvre, la diarrhée et des douleurs abdominales peuvent indiquer une infection parasitaire.
Infections parasitaires Symptômes
#5

Quel rôle des examens d'imagerie ?

Les examens d'imagerie aident à visualiser les infections internes, comme les abcès.
Imagerie médicale Infections

Symptômes 5

#1

Quels sont les symptômes d'une infection bactérienne ?

Fièvre, douleur, rougeur et gonflement sont des symptômes courants d'infections bactériennes.
Infections bactériennes Symptômes
#2

Comment reconnaître une infection virale ?

Les infections virales se manifestent souvent par de la fièvre, de la fatigue et des douleurs musculaires.
Infections virales Symptômes
#3

Quels signes d'une mycose ?

Démangeaisons, rougeurs et éruptions cutanées sont des signes fréquents de mycose.
Mycoses Symptômes
#4

Quels symptômes d'une infection parasitaire ?

Les infections parasitaires peuvent provoquer des douleurs abdominales, des nausées et de la fatigue.
Infections parasitaires Symptômes
#5

Comment se manifeste une septicémie ?

La septicémie se manifeste par une fièvre élevée, des frissons et une confusion mentale.
Septicémie Symptômes

Prévention 5

#1

Comment prévenir les infections bactériennes ?

Se laver les mains régulièrement et éviter le contact avec des personnes malades aide à prévenir les infections.
Prévention des infections Infections bactériennes
#2

Quelles mesures pour éviter les infections virales ?

La vaccination et l'hygiène respiratoire sont essentielles pour prévenir les infections virales.
Prévention des infections Infections virales
#3

Comment prévenir les mycoses ?

Maintenir une bonne hygiène corporelle et éviter les environnements humides aide à prévenir les mycoses.
Prévention des mycoses Hygiène
#4

Quelles précautions contre les infections parasitaires ?

Éviter l'eau contaminée et consommer des aliments bien cuits aide à prévenir les infections parasitaires.
Prévention des infections Infections parasitaires
#5

Quel rôle des antibiotiques en prévention ?

Les antibiotiques peuvent être utilisés en prophylaxie pour prévenir certaines infections après une exposition.
Antibiotiques Prévention des infections

Traitements 5

#1

Quels antibiotiques pour une infection bactérienne ?

Les pénicillines, céphalosporines et macrolides sont couramment utilisés pour traiter les infections bactériennes.
Antibiotiques Infections bactériennes
#2

Comment traiter une infection virale ?

Les antiviraux et les soins symptomatiques sont utilisés pour traiter les infections virales.
Antiviraux Infections virales
#3

Quels antifongiques pour les mycoses ?

Les azoles et les échinocandines sont des antifongiques couramment prescrits pour les mycoses.
Antifongiques Mycoses
#4

Comment traiter une infection parasitaire ?

Les antiparasitaires comme la mébendazole ou l'ivermectine sont utilisés pour traiter les infections parasitaires.
Antiparasitaires Infections parasitaires
#5

Quel est le rôle des vaccins ?

Les vaccins préviennent certaines infections en stimulant le système immunitaire.
Vaccins Prévention des infections

Complications 5

#1

Quelles complications des infections bactériennes ?

Les infections bactériennes peuvent entraîner des complications comme des abcès, septicémie ou choc septique.
Complications Infections bactériennes
#2

Quels risques d'infections virales ?

Les infections virales peuvent causer des complications respiratoires, neurologiques ou cardiaques.
Complications Infections virales
#3

Quelles complications des mycoses ?

Les mycoses peuvent entraîner des infections systémiques, surtout chez les immunodéprimés.
Complications Mycoses
#4

Quels dangers des infections parasitaires ?

Les infections parasitaires peuvent causer des dommages organiques et des carences nutritionnelles.
Complications Infections parasitaires
#5

Comment les infections peuvent-elles affecter le système immunitaire ?

Les infections chroniques peuvent affaiblir le système immunitaire, rendant l'individu plus vulnérable.
Système immunitaire Infections

Facteurs de risque 5

#1

Quels sont les facteurs de risque d'infections bactériennes ?

L'âge avancé, le diabète et l'immunodépression augmentent le risque d'infections bactériennes.
Facteurs de risque Infections bactériennes
#2

Quels facteurs favorisent les infections virales ?

Le stress, la fatigue et une mauvaise hygiène augmentent le risque d'infections virales.
Facteurs de risque Infections virales
#3

Quels risques pour les mycoses ?

Les personnes immunodéprimées et celles avec une mauvaise hygiène sont plus à risque de mycoses.
Facteurs de risque Mycoses
#4

Quels facteurs de risque pour les infections parasitaires ?

Voyager dans des zones endommagées et consommer de l'eau non traitée augmentent le risque d'infections parasitaires.
Facteurs de risque Infections parasitaires
#5

Quel impact de l'environnement sur les infections ?

Un environnement insalubre et la promiscuité favorisent la propagation des infections.
Environnement Infections
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Anti-infectieux : Questions médicales les plus fréquentes", "headline": "Anti-infectieux : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Anti-infectieux : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-08", "dateModified": "2025-05-03", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Anti-infectieux" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Utilisations thérapeutiques", "url": "https://questionsmedicales.fr/mesh/D045506", "about": { "@type": "MedicalCondition", "name": "Utilisations thérapeutiques", "code": { "@type": "MedicalCode", "code": "D045506", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Antibactériens", "alternateName": "Anti-Bacterial Agents", "url": "https://questionsmedicales.fr/mesh/D000900", "about": { "@type": "MedicalCondition", "name": "Antibactériens", "code": { "@type": "MedicalCode", "code": "D000900", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.085" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Antitréponémiques", "alternateName": "Antitreponemal Agents", "url": "https://questionsmedicales.fr/mesh/D000993", "about": { "@type": "MedicalCondition", "name": "Antitréponémiques", "code": { "@type": "MedicalCode", "code": "D000993", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.085.222" } } }, { "@type": "MedicalWebPage", "name": "Antituberculeux", "alternateName": "Antitubercular Agents", "url": "https://questionsmedicales.fr/mesh/D000995", "about": { "@type": "MedicalCondition", "name": "Antituberculeux", "code": { "@type": "MedicalCode", "code": "D000995", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.085.255" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Antibiotiques antituberculeux", "alternateName": "Antibiotics, Antitubercular", "url": "https://questionsmedicales.fr/mesh/D000904", "about": { "@type": "MedicalCondition", "name": "Antibiotiques antituberculeux", "code": { "@type": "MedicalCode", "code": "D000904", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.085.255.135" } } } ] }, { "@type": "MedicalWebPage", "name": "Antibiotiques antituberculeux", "alternateName": "Antibiotics, Antitubercular", "url": "https://questionsmedicales.fr/mesh/D000904", "about": { "@type": "MedicalCondition", "name": "Antibiotiques antituberculeux", "code": { "@type": "MedicalCode", "code": "D000904", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.085.255.135" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs des bêta-lactamases", "alternateName": "beta-Lactamase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065093", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs des bêta-lactamases", "code": { "@type": "MedicalCode", "code": "D065093", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.085.516" } } }, { "@type": "MedicalWebPage", "name": "Antilépreux", "alternateName": "Leprostatic Agents", "url": "https://questionsmedicales.fr/mesh/D007917", "about": { "@type": "MedicalCondition", "name": "Antilépreux", "code": { "@type": "MedicalCode", "code": "D007917", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.085.777" } } } ] }, { "@type": "MedicalWebPage", "name": "Antifongiques", "alternateName": "Antifungal Agents", "url": "https://questionsmedicales.fr/mesh/D000935", "about": { "@type": "MedicalCondition", "name": "Antifongiques", "code": { "@type": "MedicalCode", "code": "D000935", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.136" } } }, { "@type": "MedicalWebPage", "name": "Anti-infectieux locaux", "alternateName": "Anti-Infective Agents, Local", "url": "https://questionsmedicales.fr/mesh/D000891", "about": { "@type": "MedicalCondition", "name": "Anti-infectieux locaux", "code": { "@type": "MedicalCode", "code": "D000891", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.187" } } }, { "@type": "MedicalWebPage", "name": "Anti-infectieux urinaires", "alternateName": "Anti-Infective Agents, Urinary", "url": "https://questionsmedicales.fr/mesh/D000892", "about": { "@type": "MedicalCondition", "name": "Anti-infectieux urinaires", "code": { "@type": "MedicalCode", "code": "D000892", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.237" } } }, { "@type": "MedicalWebPage", "name": "Antiparasitaires", "alternateName": "Antiparasitic Agents", "url": "https://questionsmedicales.fr/mesh/D000977", "about": { "@type": "MedicalCondition", "name": "Antiparasitaires", "code": { "@type": "MedicalCode", "code": "D000977", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.250" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Anthelminthiques", "alternateName": "Anthelmintics", "url": "https://questionsmedicales.fr/mesh/D000871", "about": { "@type": "MedicalCondition", "name": "Anthelminthiques", "code": { "@type": "MedicalCode", "code": "D000871", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.250.075" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Antihelminthiques antinématodes", "alternateName": "Antinematodal Agents", "url": "https://questionsmedicales.fr/mesh/D000969", "about": { "@type": "MedicalCondition", "name": "Antihelminthiques antinématodes", "code": { "@type": "MedicalCode", "code": "D000969", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.250.075.080" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Filaricides", "alternateName": "Filaricides", "url": "https://questionsmedicales.fr/mesh/D005369", "about": { "@type": "MedicalCondition", "name": "Filaricides", "code": { "@type": "MedicalCode", "code": "D005369", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.250.075.080.275" } } } ] }, { "@type": "MedicalWebPage", "name": "Filaricides", "alternateName": "Filaricides", "url": "https://questionsmedicales.fr/mesh/D005369", "about": { "@type": "MedicalCondition", "name": "Filaricides", "code": { "@type": "MedicalCode", "code": "D005369", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.250.075.080.275" } } }, { "@type": "MedicalWebPage", "name": "Antihelminthiques antiplathelminthes", "alternateName": "Antiplatyhelmintic Agents", "url": "https://questionsmedicales.fr/mesh/D000980", "about": { "@type": "MedicalCondition", "name": "Antihelminthiques antiplathelminthes", "code": { "@type": "MedicalCode", "code": "D000980", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.250.075.100" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Antihelminthiques anticestodes", "alternateName": "Anticestodal Agents", "url": "https://questionsmedicales.fr/mesh/D000923", "about": { "@type": "MedicalCondition", "name": "Antihelminthiques anticestodes", "code": { "@type": "MedicalCode", "code": "D000923", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.250.075.100.040" } } }, { "@type": "MedicalWebPage", "name": "Schistosomicides", "alternateName": "Schistosomicides", "url": "https://questionsmedicales.fr/mesh/D012556", "about": { "@type": "MedicalCondition", "name": "Schistosomicides", "code": { "@type": "MedicalCode", "code": "D012556", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.250.075.100.750" } } } ] }, { "@type": "MedicalWebPage", "name": "Antihelminthiques anticestodes", "alternateName": "Anticestodal Agents", "url": "https://questionsmedicales.fr/mesh/D000923", "about": { "@type": "MedicalCondition", "name": "Antihelminthiques anticestodes", "code": { "@type": "MedicalCode", "code": "D000923", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.250.075.100.040" } } }, { "@type": "MedicalWebPage", "name": "Schistosomicides", "alternateName": "Schistosomicides", "url": "https://questionsmedicales.fr/mesh/D012556", "about": { "@type": "MedicalCondition", "name": "Schistosomicides", "code": { "@type": "MedicalCode", "code": "D012556", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.250.075.100.750" } } } ] }, { "@type": "MedicalWebPage", "name": "Antihelminthiques antinématodes", "alternateName": "Antinematodal Agents", "url": "https://questionsmedicales.fr/mesh/D000969", "about": { "@type": "MedicalCondition", "name": "Antihelminthiques antinématodes", "code": { "@type": "MedicalCode", "code": "D000969", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.250.075.080" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Filaricides", "alternateName": "Filaricides", "url": "https://questionsmedicales.fr/mesh/D005369", "about": { "@type": "MedicalCondition", "name": "Filaricides", "code": { "@type": "MedicalCode", "code": "D005369", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.250.075.080.275" } } } ] }, { "@type": "MedicalWebPage", "name": "Filaricides", "alternateName": "Filaricides", "url": "https://questionsmedicales.fr/mesh/D005369", "about": { "@type": "MedicalCondition", "name": "Filaricides", "code": { "@type": "MedicalCode", "code": "D005369", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.250.075.080.275" } } }, { "@type": "MedicalWebPage", "name": "Antihelminthiques antiplathelminthes", "alternateName": "Antiplatyhelmintic Agents", "url": "https://questionsmedicales.fr/mesh/D000980", "about": { "@type": "MedicalCondition", "name": "Antihelminthiques antiplathelminthes", "code": { "@type": "MedicalCode", "code": "D000980", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.250.075.100" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Antihelminthiques anticestodes", "alternateName": "Anticestodal Agents", "url": "https://questionsmedicales.fr/mesh/D000923", "about": { "@type": "MedicalCondition", "name": "Antihelminthiques anticestodes", "code": { "@type": "MedicalCode", "code": "D000923", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.250.075.100.040" } } }, { "@type": "MedicalWebPage", "name": "Schistosomicides", "alternateName": "Schistosomicides", "url": "https://questionsmedicales.fr/mesh/D012556", "about": { "@type": "MedicalCondition", "name": "Schistosomicides", "code": { "@type": "MedicalCode", "code": "D012556", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.250.075.100.750" } } } ] }, { "@type": "MedicalWebPage", "name": "Antihelminthiques anticestodes", "alternateName": "Anticestodal Agents", "url": "https://questionsmedicales.fr/mesh/D000923", "about": { "@type": "MedicalCondition", "name": "Antihelminthiques anticestodes", "code": { "@type": "MedicalCode", "code": "D000923", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.250.075.100.040" } } }, { "@type": "MedicalWebPage", "name": "Schistosomicides", "alternateName": "Schistosomicides", "url": "https://questionsmedicales.fr/mesh/D012556", "about": { "@type": "MedicalCondition", "name": "Schistosomicides", "code": { "@type": "MedicalCode", "code": "D012556", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.250.075.100.750" } } }, { "@type": "MedicalWebPage", "name": "Antiprotozoaires", "alternateName": "Antiprotozoal Agents", "url": "https://questionsmedicales.fr/mesh/D000981", "about": { "@type": "MedicalCondition", "name": "Antiprotozoaires", "code": { "@type": "MedicalCode", "code": "D000981", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.250.100" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Antiamibiens", "alternateName": "Amebicides", "url": "https://questionsmedicales.fr/mesh/D000563", "about": { "@type": "MedicalCondition", "name": "Antiamibiens", "code": { "@type": "MedicalCode", "code": "D000563", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.250.100.055" } } }, { "@type": "MedicalWebPage", "name": "Antipaludiques", "alternateName": "Antimalarials", "url": "https://questionsmedicales.fr/mesh/D000962", "about": { "@type": "MedicalCondition", "name": "Antipaludiques", "code": { "@type": "MedicalCode", "code": "D000962", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.250.100.085" } } }, { "@type": "MedicalWebPage", "name": "Antitrichomonas", "alternateName": "Antitrichomonal Agents", "url": "https://questionsmedicales.fr/mesh/D000994", "about": { "@type": "MedicalCondition", "name": "Antitrichomonas", "code": { "@type": "MedicalCode", "code": "D000994", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.250.100.115" } } }, { "@type": "MedicalWebPage", "name": "Coccidiostatiques", "alternateName": "Coccidiostats", "url": "https://questionsmedicales.fr/mesh/D003049", "about": { "@type": "MedicalCondition", "name": "Coccidiostatiques", "code": { "@type": "MedicalCode", "code": "D003049", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.250.100.170" } } }, { "@type": "MedicalWebPage", "name": "Trypanocides", "alternateName": "Trypanocidal Agents", "url": "https://questionsmedicales.fr/mesh/D014344", "about": { "@type": "MedicalCondition", "name": "Trypanocides", "code": { "@type": "MedicalCode", "code": "D014344", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.250.100.875" } } } ] }, { "@type": "MedicalWebPage", "name": "Antiamibiens", "alternateName": "Amebicides", "url": "https://questionsmedicales.fr/mesh/D000563", "about": { "@type": "MedicalCondition", "name": "Antiamibiens", "code": { "@type": "MedicalCode", "code": "D000563", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.250.100.055" } } }, { "@type": "MedicalWebPage", "name": "Antipaludiques", "alternateName": "Antimalarials", "url": "https://questionsmedicales.fr/mesh/D000962", "about": { "@type": "MedicalCondition", "name": "Antipaludiques", "code": { "@type": "MedicalCode", "code": "D000962", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.250.100.085" } } }, { "@type": "MedicalWebPage", "name": "Antitrichomonas", "alternateName": "Antitrichomonal Agents", "url": "https://questionsmedicales.fr/mesh/D000994", "about": { "@type": "MedicalCondition", "name": "Antitrichomonas", "code": { "@type": "MedicalCode", "code": "D000994", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.250.100.115" } } }, { "@type": "MedicalWebPage", "name": "Coccidiostatiques", "alternateName": "Coccidiostats", "url": "https://questionsmedicales.fr/mesh/D003049", "about": { "@type": "MedicalCondition", "name": "Coccidiostatiques", "code": { "@type": "MedicalCode", "code": "D003049", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.250.100.170" } } }, { "@type": "MedicalWebPage", "name": "Trypanocides", "alternateName": "Trypanocidal Agents", "url": "https://questionsmedicales.fr/mesh/D014344", "about": { "@type": "MedicalCondition", "name": "Trypanocides", "code": { "@type": "MedicalCode", "code": "D014344", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.250.100.875" } } } ] }, { "@type": "MedicalWebPage", "name": "Antiviraux", "alternateName": "Antiviral Agents", "url": "https://questionsmedicales.fr/mesh/D000998", "about": { "@type": "MedicalCondition", "name": "Antiviraux", "code": { "@type": "MedicalCode", "code": "D000998", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.388" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Antirétroviraux", "alternateName": "Anti-Retroviral Agents", "url": "https://questionsmedicales.fr/mesh/D044966", "about": { "@type": "MedicalCondition", "name": "Antirétroviraux", "code": { "@type": "MedicalCode", "code": "D044966", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.388.077" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Agents antiVIH", "alternateName": "Anti-HIV Agents", "url": "https://questionsmedicales.fr/mesh/D019380", "about": { "@type": "MedicalCondition", "name": "Agents antiVIH", "code": { "@type": "MedicalCode", "code": "D019380", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.388.077.088" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Antagonistes des récepteurs CCR5", "alternateName": "CCR5 Receptor Antagonists", "url": "https://questionsmedicales.fr/mesh/D065100", "about": { "@type": "MedicalCondition", "name": "Antagonistes des récepteurs CCR5", "code": { "@type": "MedicalCode", "code": "D065100", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.388.077.088.104" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de l'intégrase du VIH", "alternateName": "HIV Integrase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D019428", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de l'intégrase du VIH", "code": { "@type": "MedicalCode", "code": "D019428", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.388.077.088.314" } } } ] }, { "@type": "MedicalWebPage", "name": "Antagonistes des récepteurs CCR5", "alternateName": "CCR5 Receptor Antagonists", "url": "https://questionsmedicales.fr/mesh/D065100", "about": { "@type": "MedicalCondition", "name": "Antagonistes des récepteurs CCR5", "code": { "@type": "MedicalCode", "code": "D065100", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.388.077.088.104" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de l'intégrase du VIH", "alternateName": "HIV Integrase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D019428", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de l'intégrase du VIH", "code": { "@type": "MedicalCode", "code": "D019428", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.388.077.088.314" } } } ] }, { "@type": "MedicalWebPage", "name": "Agents antiVIH", "alternateName": "Anti-HIV Agents", "url": "https://questionsmedicales.fr/mesh/D019380", "about": { "@type": "MedicalCondition", "name": "Agents antiVIH", "code": { "@type": "MedicalCode", "code": "D019380", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.388.077.088" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Antagonistes des récepteurs CCR5", "alternateName": "CCR5 Receptor Antagonists", "url": "https://questionsmedicales.fr/mesh/D065100", "about": { "@type": "MedicalCondition", "name": "Antagonistes des récepteurs CCR5", "code": { "@type": "MedicalCode", "code": "D065100", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.388.077.088.104" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de l'intégrase du VIH", "alternateName": "HIV Integrase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D019428", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de l'intégrase du VIH", "code": { "@type": "MedicalCode", "code": "D019428", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.388.077.088.314" } } } ] }, { "@type": "MedicalWebPage", "name": "Antagonistes des récepteurs CCR5", "alternateName": "CCR5 Receptor Antagonists", "url": "https://questionsmedicales.fr/mesh/D065100", "about": { "@type": "MedicalCondition", "name": "Antagonistes des récepteurs CCR5", "code": { "@type": "MedicalCode", "code": "D065100", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.388.077.088.104" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de l'intégrase du VIH", "alternateName": "HIV Integrase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D019428", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de l'intégrase du VIH", "code": { "@type": "MedicalCode", "code": "D019428", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.388.077.088.314" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la transcriptase inverse", "alternateName": "Reverse Transcriptase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D018894", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la transcriptase inverse", "code": { "@type": "MedicalCode", "code": "D018894", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.388.308" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs des protéines de fusion virale", "alternateName": "Viral Fusion Protein Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065147", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs des protéines de fusion virale", "code": { "@type": "MedicalCode", "code": "D065147", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.388.538" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Inhibiteurs de fusion du VIH", "alternateName": "HIV Fusion Inhibitors", "url": "https://questionsmedicales.fr/mesh/D023581", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de fusion du VIH", "code": { "@type": "MedicalCode", "code": "D023581", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.388.538.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de fusion du VIH", "alternateName": "HIV Fusion Inhibitors", "url": "https://questionsmedicales.fr/mesh/D023581", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de fusion du VIH", "code": { "@type": "MedicalCode", "code": "D023581", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.388.538.500" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de protéases virales", "alternateName": "Viral Protease Inhibitors", "url": "https://questionsmedicales.fr/mesh/D000084762", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de protéases virales", "code": { "@type": "MedicalCode", "code": "D000084762", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.388.769" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Inhibiteurs des protéases des coronavirus", "alternateName": "Coronavirus Protease Inhibitors", "url": "https://questionsmedicales.fr/mesh/D000085683", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs des protéases des coronavirus", "code": { "@type": "MedicalCode", "code": "D000085683", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.388.769.250" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la protéase NS3-4A du VHC", "alternateName": "HCV NS3-4A Protease Inhibitors", "url": "https://questionsmedicales.fr/mesh/D000088802", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la protéase NS3-4A du VHC", "code": { "@type": "MedicalCode", "code": "D000088802", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.388.769.375" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de protéase du VIH", "alternateName": "HIV Protease Inhibitors", "url": "https://questionsmedicales.fr/mesh/D017320", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de protéase du VIH", "code": { "@type": "MedicalCode", "code": "D017320", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.388.769.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Inhibiteurs des protéases des coronavirus", "alternateName": "Coronavirus Protease Inhibitors", "url": "https://questionsmedicales.fr/mesh/D000085683", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs des protéases des coronavirus", "code": { "@type": "MedicalCode", "code": "D000085683", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.388.769.250" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la protéase NS3-4A du VHC", "alternateName": "HCV NS3-4A Protease Inhibitors", "url": "https://questionsmedicales.fr/mesh/D000088802", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la protéase NS3-4A du VHC", "code": { "@type": "MedicalCode", "code": "D000088802", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.388.769.375" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de protéase du VIH", "alternateName": "HIV Protease Inhibitors", "url": "https://questionsmedicales.fr/mesh/D017320", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de protéase du VIH", "code": { "@type": "MedicalCode", "code": "D017320", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.122.388.769.500" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Anti-infectieux", "alternateName": "Anti-Infective Agents", "code": { "@type": "MedicalCode", "code": "D000890", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Yang Cai", "url": "https://questionsmedicales.fr/author/Yang%20Cai", "affiliation": { "@type": "Organization", "name": "Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, 3584 CG, Utrecht, the Netherlands." } }, { "@type": "Person", "name": "Gert Folkerts", "url": "https://questionsmedicales.fr/author/Gert%20Folkerts", "affiliation": { "@type": "Organization", "name": "Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, 3584 CG, Utrecht, the Netherlands." } }, { "@type": "Person", "name": "Saskia Braber", "url": "https://questionsmedicales.fr/author/Saskia%20Braber", "affiliation": { "@type": "Organization", "name": "Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, 3584 CG, Utrecht, the Netherlands. Electronic address: s.braber@uu.nl." } }, { "@type": "Person", "name": "Jason A Roberts", "url": "https://questionsmedicales.fr/author/Jason%20A%20Roberts", "affiliation": { "@type": "Organization", "name": "5 Centre for Translational Anti-Infective Pharmacodynamics, School of Pharmacy, The University of Queensland, Brisbane, QLD, Australia." } }, { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "National survey questionnaire on the diagnosis and treatment status of", "datePublished": "2024-09-11", "url": "https://questionsmedicales.fr/article/39324164", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fpubh.2024.1433139" } }, { "@type": "ScholarlyArticle", "name": "Gonad contact shielding in digital radiography: A questionnaire survey.", "datePublished": "2022-11-24", "url": "https://questionsmedicales.fr/article/36521379", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ejrad.2022.110620" } }, { "@type": "ScholarlyArticle", "name": "Overwork among resident physicians: national questionnaire survey results.", "datePublished": "2022-10-20", "url": "https://questionsmedicales.fr/article/36266644", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12909-022-03789-7" } }, { "@type": "ScholarlyArticle", "name": "Analysis and modeling of myopia-related factors based on questionnaire survey.", "datePublished": "2022-10-05", "url": "https://questionsmedicales.fr/article/36252365", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.compbiomed.2022.106162" } }, { "@type": "ScholarlyArticle", "name": "Breastfeeding in primiparous women - expectations and reality: a prospective questionnaire survey.", "datePublished": "2023-09-09", "url": "https://questionsmedicales.fr/article/37689660", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12884-023-05971-1" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Actions chimiques et utilisations", "item": "https://questionsmedicales.fr/mesh/D020164" }, { "@type": "ListItem", "position": 3, "name": "Actions pharmacologiques", "item": "https://questionsmedicales.fr/mesh/D020228" }, { "@type": "ListItem", "position": 4, "name": "Utilisations thérapeutiques", "item": "https://questionsmedicales.fr/mesh/D045506" }, { "@type": "ListItem", "position": 5, "name": "Anti-infectieux", "item": "https://questionsmedicales.fr/mesh/D000890" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Anti-infectieux - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Anti-infectieux", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-13", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Anti-infectieux", "description": "Comment diagnostiquer une infection bactérienne ?\nQuels tests pour une infection virale ?\nComment identifier une mycose ?\nQuels signes indiquent une infection parasitaire ?\nQuel rôle des examens d'imagerie ?", "url": "https://questionsmedicales.fr/mesh/D000890?mesh_terms=Surveys+and+Questionnaires#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Anti-infectieux", "description": "Quels sont les symptômes d'une infection bactérienne ?\nComment reconnaître une infection virale ?\nQuels signes d'une mycose ?\nQuels symptômes d'une infection parasitaire ?\nComment se manifeste une septicémie ?", "url": "https://questionsmedicales.fr/mesh/D000890?mesh_terms=Surveys+and+Questionnaires#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Anti-infectieux", "description": "Comment prévenir les infections bactériennes ?\nQuelles mesures pour éviter les infections virales ?\nComment prévenir les mycoses ?\nQuelles précautions contre les infections parasitaires ?\nQuel rôle des antibiotiques en prévention ?", "url": "https://questionsmedicales.fr/mesh/D000890?mesh_terms=Surveys+and+Questionnaires#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Anti-infectieux", "description": "Quels antibiotiques pour une infection bactérienne ?\nComment traiter une infection virale ?\nQuels antifongiques pour les mycoses ?\nComment traiter une infection parasitaire ?\nQuel est le rôle des vaccins ?", "url": "https://questionsmedicales.fr/mesh/D000890?mesh_terms=Surveys+and+Questionnaires#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Anti-infectieux", "description": "Quelles complications des infections bactériennes ?\nQuels risques d'infections virales ?\nQuelles complications des mycoses ?\nQuels dangers des infections parasitaires ?\nComment les infections peuvent-elles affecter le système immunitaire ?", "url": "https://questionsmedicales.fr/mesh/D000890?mesh_terms=Surveys+and+Questionnaires#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Anti-infectieux", "description": "Quels sont les facteurs de risque d'infections bactériennes ?\nQuels facteurs favorisent les infections virales ?\nQuels risques pour les mycoses ?\nQuels facteurs de risque pour les infections parasitaires ?\nQuel impact de l'environnement sur les infections ?", "url": "https://questionsmedicales.fr/mesh/D000890?mesh_terms=Surveys+and+Questionnaires#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection bactérienne ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic se fait par des tests de culture et des analyses sanguines." } }, { "@type": "Question", "name": "Quels tests pour une infection virale ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests PCR et les sérologies sont utilisés pour détecter les infections virales." } }, { "@type": "Question", "name": "Comment identifier une mycose ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Un examen microscopique et des cultures fongiques permettent d'identifier les mycoses." } }, { "@type": "Question", "name": "Quels signes indiquent une infection parasitaire ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la fièvre, la diarrhée et des douleurs abdominales peuvent indiquer une infection parasitaire." } }, { "@type": "Question", "name": "Quel rôle des examens d'imagerie ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les examens d'imagerie aident à visualiser les infections internes, comme les abcès." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une infection bactérienne ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, douleur, rougeur et gonflement sont des symptômes courants d'infections bactériennes." } }, { "@type": "Question", "name": "Comment reconnaître une infection virale ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les infections virales se manifestent souvent par de la fièvre, de la fatigue et des douleurs musculaires." } }, { "@type": "Question", "name": "Quels signes d'une mycose ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Démangeaisons, rougeurs et éruptions cutanées sont des signes fréquents de mycose." } }, { "@type": "Question", "name": "Quels symptômes d'une infection parasitaire ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les infections parasitaires peuvent provoquer des douleurs abdominales, des nausées et de la fatigue." } }, { "@type": "Question", "name": "Comment se manifeste une septicémie ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "La septicémie se manifeste par une fièvre élevée, des frissons et une confusion mentale." } }, { "@type": "Question", "name": "Comment prévenir les infections bactériennes ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Se laver les mains régulièrement et éviter le contact avec des personnes malades aide à prévenir les infections." } }, { "@type": "Question", "name": "Quelles mesures pour éviter les infections virales ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "La vaccination et l'hygiène respiratoire sont essentielles pour prévenir les infections virales." } }, { "@type": "Question", "name": "Comment prévenir les mycoses ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une bonne hygiène corporelle et éviter les environnements humides aide à prévenir les mycoses." } }, { "@type": "Question", "name": "Quelles précautions contre les infections parasitaires ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Éviter l'eau contaminée et consommer des aliments bien cuits aide à prévenir les infections parasitaires." } }, { "@type": "Question", "name": "Quel rôle des antibiotiques en prévention ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les antibiotiques peuvent être utilisés en prophylaxie pour prévenir certaines infections après une exposition." } }, { "@type": "Question", "name": "Quels antibiotiques pour une infection bactérienne ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les pénicillines, céphalosporines et macrolides sont couramment utilisés pour traiter les infections bactériennes." } }, { "@type": "Question", "name": "Comment traiter une infection virale ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les antiviraux et les soins symptomatiques sont utilisés pour traiter les infections virales." } }, { "@type": "Question", "name": "Quels antifongiques pour les mycoses ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les azoles et les échinocandines sont des antifongiques couramment prescrits pour les mycoses." } }, { "@type": "Question", "name": "Comment traiter une infection parasitaire ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les antiparasitaires comme la mébendazole ou l'ivermectine sont utilisés pour traiter les infections parasitaires." } }, { "@type": "Question", "name": "Quel est le rôle des vaccins ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccins préviennent certaines infections en stimulant le système immunitaire." } }, { "@type": "Question", "name": "Quelles complications des infections bactériennes ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les infections bactériennes peuvent entraîner des complications comme des abcès, septicémie ou choc septique." } }, { "@type": "Question", "name": "Quels risques d'infections virales ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Les infections virales peuvent causer des complications respiratoires, neurologiques ou cardiaques." } }, { "@type": "Question", "name": "Quelles complications des mycoses ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les mycoses peuvent entraîner des infections systémiques, surtout chez les immunodéprimés." } }, { "@type": "Question", "name": "Quels dangers des infections parasitaires ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les infections parasitaires peuvent causer des dommages organiques et des carences nutritionnelles." } }, { "@type": "Question", "name": "Comment les infections peuvent-elles affecter le système immunitaire ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les infections chroniques peuvent affaiblir le système immunitaire, rendant l'individu plus vulnérable." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque d'infections bactériennes ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'âge avancé, le diabète et l'immunodépression augmentent le risque d'infections bactériennes." } }, { "@type": "Question", "name": "Quels facteurs favorisent les infections virales ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Le stress, la fatigue et une mauvaise hygiène augmentent le risque d'infections virales." } }, { "@type": "Question", "name": "Quels risques pour les mycoses ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes immunodéprimées et celles avec une mauvaise hygiène sont plus à risque de mycoses." } }, { "@type": "Question", "name": "Quels facteurs de risque pour les infections parasitaires ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Voyager dans des zones endommagées et consommer de l'eau non traitée augmentent le risque d'infections parasitaires." } }, { "@type": "Question", "name": "Quel impact de l'environnement sur les infections ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Un environnement insalubre et la promiscuité favorisent la propagation des infections." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 03/05/2025

Contenu vérifié selon les dernières recommandations médicales

Sous-catégories

34 au total
└─

Antibactériens

Anti-Bacterial Agents D000900 - D27.505.954.122.085
└─

Antifongiques

Antifungal Agents D000935 - D27.505.954.122.136
└─

Anti-infectieux locaux

Anti-Infective Agents, Local D000891 - D27.505.954.122.187
└─

Anti-infectieux urinaires

Anti-Infective Agents, Urinary D000892 - D27.505.954.122.237
└─

Antiparasitaires

Antiparasitic Agents D000977 - D27.505.954.122.250
└─

Antiviraux

Antiviral Agents D000998 - D27.505.954.122.388
└─└─

Antitréponémiques

Antitreponemal Agents D000993 - D27.505.954.122.085.222
└─└─

Antituberculeux

Antitubercular Agents D000995 - D27.505.954.122.085.255
└─└─

Inhibiteurs des bêta-lactamases

beta-Lactamase Inhibitors D065093 - D27.505.954.122.085.516
└─└─

Antilépreux

Leprostatic Agents D007917 - D27.505.954.122.085.777
└─└─

Anthelminthiques

Anthelmintics D000871 - D27.505.954.122.250.075
└─└─

Antiprotozoaires

Antiprotozoal Agents D000981 - D27.505.954.122.250.100
└─└─

Antirétroviraux

Anti-Retroviral Agents D044966 - D27.505.954.122.388.077
└─└─

Inhibiteurs de la transcriptase inverse

Reverse Transcriptase Inhibitors D018894 - D27.505.954.122.388.308
└─└─

Inhibiteurs des protéines de fusion virale

Viral Fusion Protein Inhibitors D065147 - D27.505.954.122.388.538
└─└─

Inhibiteurs de protéases virales

Viral Protease Inhibitors D000084762 - D27.505.954.122.388.769
└─└─└─

Antibiotiques antituberculeux

Antibiotics, Antitubercular D000904 - D27.505.954.122.085.255.135
└─└─└─

Antihelminthiques antinématodes

Antinematodal Agents D000969 - D27.505.954.122.250.075.080
└─└─└─

Antihelminthiques antiplathelminthes

Antiplatyhelmintic Agents D000980 - D27.505.954.122.250.075.100
└─└─└─

Antiamibiens

Amebicides D000563 - D27.505.954.122.250.100.055
└─└─└─

Antipaludiques

Antimalarials D000962 - D27.505.954.122.250.100.085
└─└─└─

Antitrichomonas

Antitrichomonal Agents D000994 - D27.505.954.122.250.100.115
└─└─└─

Coccidiostatiques

Coccidiostats D003049 - D27.505.954.122.250.100.170
└─└─└─

Trypanocides

Trypanocidal Agents D014344 - D27.505.954.122.250.100.875
└─└─└─

Agents antiVIH

Anti-HIV Agents D019380 - D27.505.954.122.388.077.088
└─└─└─

Inhibiteurs de fusion du VIH

HIV Fusion Inhibitors D023581 - D27.505.954.122.388.538.500
└─└─└─

Inhibiteurs des protéases des coronavirus

Coronavirus Protease Inhibitors D000085683 - D27.505.954.122.388.769.250
└─└─└─

Inhibiteurs de la protéase NS3-4A du VHC

HCV NS3-4A Protease Inhibitors D000088802 - D27.505.954.122.388.769.375
└─└─└─

Inhibiteurs de protéase du VIH

HIV Protease Inhibitors D017320 - D27.505.954.122.388.769.500
└─└─└─└─

Filaricides

Filaricides D005369 - D27.505.954.122.250.075.080.275
└─└─└─└─

Antihelminthiques anticestodes

Anticestodal Agents D000923 - D27.505.954.122.250.075.100.040
└─└─└─└─

Schistosomicides

Schistosomicides D012556 - D27.505.954.122.250.075.100.750
└─└─└─└─

Antagonistes des récepteurs CCR5

CCR5 Receptor Antagonists D065100 - D27.505.954.122.388.077.088.104
└─└─└─└─

Inhibiteurs de l'intégrase du VIH

HIV Integrase Inhibitors D019428 - D27.505.954.122.388.077.088.314

Auteurs principaux

Yang Cai

2 publications dans cette catégorie

Affiliations :
  • Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, 3584 CG, Utrecht, the Netherlands.

Gert Folkerts

2 publications dans cette catégorie

Affiliations :
  • Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, 3584 CG, Utrecht, the Netherlands.

Saskia Braber

2 publications dans cette catégorie

Affiliations :
  • Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, 3584 CG, Utrecht, the Netherlands. Electronic address: s.braber@uu.nl.

Jason A Roberts

2 publications dans cette catégorie

Affiliations :
  • 5 Centre for Translational Anti-Infective Pharmacodynamics, School of Pharmacy, The University of Queensland, Brisbane, QLD, Australia.
  • 6 Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.
  • 7 Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.

None None

2 publications dans cette catégorie

Publications dans "Anti-infectieux" :

Arnab K Chatterjee

1 publication dans cette catégorie

Affiliations :
  • Calibr-Skaggs Institute of Innovation Medicines, Scripps Research, La Jolla, CA, United States. Electronic address: achatterjee@scripps.edu.
Publications dans "Anti-infectieux" :

Jos P M van Putten

1 publication dans cette catégorie

Affiliations :
  • Department of Infectious Diseases and Immunology, Utrecht University, 3584 CL, Utrecht, the Netherlands.
Publications dans "Anti-infectieux" :

Myrthe S Gilbert

1 publication dans cette catégorie

Affiliations :
  • Animal Nutrition Group, Wageningen University, 6700 AH, Wageningen, the Netherlands.
Publications dans "Anti-infectieux" :

Walter J J Gerrits

1 publication dans cette catégorie

Affiliations :
  • Animal Nutrition Group, Wageningen University, 6700 AH, Wageningen, the Netherlands.
Publications dans "Anti-infectieux" :

Antoine G Schneider

1 publication dans cette catégorie

Affiliations :
  • Adult Intensive Care Unit, BH08-610, Centre Hospitalier Universitaire Vaudois (CHUV), 46, Avenue du Bugnon 1011, Lausanne, Switzerland. antoine.schneider@chuv.ch.
  • Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland. antoine.schneider@chuv.ch.
Publications dans "Anti-infectieux" :

Pascal André

1 publication dans cette catégorie

Affiliations :
  • Clinical Pharmacology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
Publications dans "Anti-infectieux" :

Joerg Scheier

1 publication dans cette catégorie

Affiliations :
  • CytoSorbents Europe GmbH, Berlin, Germany.
Publications dans "Anti-infectieux" :

Monika Schmidt

1 publication dans cette catégorie

Affiliations :
  • Medical Competence Center Berlin/Brandenburg C/o HCx Consulting GmbH, Wendisch Rietz, Germany.
Publications dans "Anti-infectieux" :

Heiko Ziervogel

1 publication dans cette catégorie

Affiliations :
  • Medical Competence Center Berlin/Brandenburg C/o HCx Consulting GmbH, Wendisch Rietz, Germany.
Publications dans "Anti-infectieux" :

Thierry Buclin

1 publication dans cette catégorie

Affiliations :
  • Clinical Pharmacology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
Publications dans "Anti-infectieux" :

Detlef Kindgen-Milles

1 publication dans cette catégorie

Affiliations :
  • Department of Anesthesiology, University Hospital Düsseldorf, Düsseldorf, Germany.
Publications dans "Anti-infectieux" :

Martin Šíma

1 publication dans cette catégorie

Affiliations :
  • Department of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 00 Prague, Czech Republic.
Publications dans "Anti-infectieux" :

Ondřej Slanař

1 publication dans cette catégorie

Affiliations :
  • Department of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 00 Prague, Czech Republic.
Publications dans "Anti-infectieux" :

Prisca Lagardère

1 publication dans cette catégorie

Affiliations :
  • IBMM, University of Montpellier, CNRS, ENSCM, 34293 Montpellier, France.
Publications dans "Anti-infectieux" :

Cyril Fersing

1 publication dans cette catégorie

Affiliations :
  • IBMM, University of Montpellier, CNRS, ENSCM, 34293 Montpellier, France.
  • Nuclear Medicine Department, Montpellier Cancer Institute (ICM), University of Montpellier, 208 Avenue des Apothicaires, CEDEX 5, 34298 Montpellier, France.
Publications dans "Anti-infectieux" :

Sources (10000 au total)

National survey questionnaire on the diagnosis and treatment status of

The Maastricht VI/Florence Consensus and Chinese National Consensus Report provide comprehensive guidelines for treating... Chinese medical staff attending gastrointestinal conferences across various regions were selected for this study. The questionnaire included: 1. the number of patients with peptic ulcer bleeding in ho... Across all levels of Chinese hospitals, the urea breath test was the most commonly used method for detecting... There is a need for an enhanced understanding of and adherence to guidelines for...

Gonad contact shielding in digital radiography: A questionnaire survey.

The use of gonad contact shielding (GCS) in radiology departments has varied across countries, possibly because, until recently, there was no agreed consensus with mixed evidence supporting its use. T... An online survey was sent via email to potential participants through the Society of Medical Radiographers Malta (SRM) as well as social media posts on local radiography pages. Descriptive and inferen... Almost half of the registered radiographers working in radiology departments in Malta (n = 101/203) completed the survey (49.7 % response rate). 61.4 % of participating radiographers indicated they 'o... Some misconceptions and uncertainties among radiographers concerning the benefits and risks of using GCS were noted. Local radiology departments should look into their protocols and assess the need fo...

Overwork among resident physicians: national questionnaire survey results.

Residents experience the longest working hours among physicians. Thus, it would be beneficial to perform a nationwide survey in Japan on residents' long work hours and the background factors promoting... The survey was sent to 924 hospitals. The physicians' general attributes, work hours and conditions, and employers' foundational entities were explored. Multiple logistic regression analysis was perfo... Of the 4306 resident physicians who responded, 67% had ≥ 60 in-hospital hours/week and 27% had ≥ 80 h/week; 51% were on-call ≥ four times/month. Many of them hoped for increased remuneration. Addition... Understanding the factors that increase the likelihood of residents working very long hours could aid in making targeted changes to address the specific concerns. Moreover, reducing working hours to a...

Breastfeeding in primiparous women - expectations and reality: a prospective questionnaire survey.

Breastfeeding provides the optimal nutrition for infants and offers numerous benefits for both mother and child. The World Health Organisation recommends exclusive breastfeeding during the first 6 mon... In this prospective, questionnaire-based study conducted between 2020 and 2022, primiparous women were asked to complete three questionnaires at three defined survey time points (routine prepartum pre... A total of 140 women were included and returned all three questionnaires. Fifty-eight percent performed breastfeeding exclusively at least until their baby had reached the age of 6 months, whereas 20%... Breastfeeding behaviour and duration are influenced by multiple factors. Although certain sociodemographic factors are unalterable, comprehensive prepartum knowledge transfer and postpartum midwifery ... The study was retrospectively registered at the German Clinical Trials Register (Deutsches Register Klinischer Studien, DRKS) on 6 December 2022 (DRKS00030763)....

Validation of the accident and emergency experience questionnaire: a cross-sectional survey.

Patient feedback is an important way for healthcare providers to understand patient experience and improve the quality of care effectively and facilitate patient-centered care in the healthcare system... Attendances aged 18 or above from all public hospitals with AEDs during 16-30 June 2016 were targeted and a cross-sectional telephone survey was conducted using AEEQ. Preliminary AEEQ consisted of 92 ... A total of 512 patients were recruited with a response rate of 54% and a mean age of 53.2 years old. The exploratory factor analysis suggested removing 7 items due to weak factor loadings and high cro... The AEEQ is a valid and reliable instrument to evaluate the AED service which helps to build the engagement platform for promoting patient-centered care between patients and frontline healthcare profe...

Validation of a COVID-19 mental health and wellness survey questionnaire.

COVID-19 affected mental health and wellbeing. Research is needed to assess its impact using validated tools. The study assessed the content validity, reliability and dimensionality of a multidimensio... An online questionnaire collected data in the second half of 2020 from adults in different countries. The questionnaire included nine sections assessing: COVID-19 experience and sociodemographic profi... The overall CVI = 0.83 with lower values for the memory items. Cronbach α for the memory items = 0.94 and ICC = 0.71. Cronbach α for PTSD items was 0.93 and ICC = 0.89. Test-retest scores varied by se... The questionnaire has good content validity and can be used to assess the impact of the pandemic in cross-sectional studies especially as individual items. The PSI and self-care strategies need revisi...

Scoping review of exposure questionnaires and surveys in interstitial lung disease.

Many interstitial lung diseases (ILDs) have clear causal relationships with environmental and occupational exposures. Exposure identification can assist with diagnosis, understanding disease pathogene... This scoping review aimed to summarise the available evidence relating to ILD exposure assessment questionnaires, identify research gaps and inform the content for a future single evidence-based ILD q... A scoping review based on Arksey and O'Malley's methodological framework was conducted.... Any questionnaire that elicited exposures specific to ILD was included. A modified COSMIN Risk of Bias Framework was used to assess quality.... Relevant articles were identified from MEDLINE and EMBASE up to 23 July 2023.... 22 exposure questionnaires were identified, including 15 generally pertaining to ILD, along with several disease-specific questionnaires for hypersensitivity pneumonitis (n=4), chronic beryllium disea... Designing a robust ILD-specific questionnaire should include an evidence-based and relevance-based approach to exposure derivation, with clinicians and patients involved in its development and tested ...